Overview

Quality of Life and Nutritional Improvements in Cirrhotic Patients

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether taking Rifaximin (Xifaxan) in conjunction with the use of nutritional concepts is effective in improving morbidity and quality of life in cirrhotic patients suffering from hepatic encephalopathy (HE).
Phase:
Phase 4
Details
Lead Sponsor:
Tampa General Hospital
Treatments:
Lactulose
Rifamycins
Rifaximin